true
Icon to close the modal
Support
Turkey
Phone Icon
+90 216 680 10 02
Fax Icon
+90 216 680 16 55
CC_Turkey@bd.com
Modal Close Icon
Icon to close thank you modal
Thank you for contacting our sales team!
A sales representive will get in touch with you shortly.
Middle East & North Africa
Phone Icon
+971 4 5592555
Fax Icon
+971 4 5592599
info_uae@bd.com
Saudi Arabia
Phone Icon
+966 11 472 7933
Fax Icon
+966 11 472 3387
Saudi_info@bd.com
Egypt
Becton Dickinson BV, Scientific Office Mivida Business Park, Building A2, 1st Floor, Office 107, New Cairo, Cairo, Egypt.

Avitene™ Ultrafoam™ Collagen Sponge

Ultrafoam™ Collagen Sponge

Contact Us
Ultra_Foam_8X12_THICK_B-2048x2048
Loading
Overview

Standardise on the proven solution for active hemostasis.

Avitene™ Microfibrillar Collagen Hemostat is an active absorbable collagen hemostat, proven to accelerate clot formation. Avitene™ effectively enhances platelet aggregation and the release of proteins to form fibrin, resulting in hemostasis.

true
Features and Benefits

MULTIPLE FORMS FOR EVERY SPECIALTY:

  • The proven solution for controlling bleeding in all surgical applications, including neurosurgery, neurology, urology, cardiovascular and general surgery1
  • Trusted by surgeons for its safety and efficacy for over 40 years.

 

 

Avitene™ Sheets (Nonwoven web)

  • Avitene™ Sheets provide the same efficacy expected from Avitene™ Flour
  • Cut to any shape or size
  • Clings tenaciously to hemorrhage
  • Ideal for use on flat surfaces or to wrap vessels and anastomosis sites
  • Available in 3.5 cm x 3.5 cm, 7.0 cm x 3.5 cm and 7.0 cm x 7.0 cm
     

Learn more

AVITENE™ FLOUR

Avitene™ Microfibrillar Collagen Hemostat Flour

    • Effective in controlling arterial bleeding1
    • Conforms and adheres to irregular spaces
    • Easy removal with irrigation and suction
    • Available in 0.5 g, 1.0 g and 5.0 g sizes

     

    Learn more

    Avitene™ Ultrafoam™ Collagen Sponge

    • Easy, effective solution for hemostasis 
    • In an animal study, UltraFoam™ Collagen without thrombin was as effective as Gelfoam® Sponge with thrombin 
    • Reduced thrombin usage may lower cost 
    • Soft, pliable sponge is ready-to-use out of the package 
    • No soaking necessary
    • Does not swell, providing predictable placement of Ultrafoam™
       

    Learn more

    EIFUs
    Resources

    References

    1. See full Instructions for Use for detailed application instructions

    Disclaimers

    • Not all products, services, claims or features of products may be available or valid in your local area. Please check with your local BD representative.

    • Please consult product labels and instructions for use for indications, contradictions, hazards, warnings, and precautions.

    Indications

    Avitene™ Ultrafoam™ sponge is indicated in surgical procedures as an adjunct to hemostasis when control of bleeding by ligature or conventional procedures is ineffective or impractical.

    Contradictions

    • Avitene™ Ultrafoam™ sponge should not be used in the closure of skin incisions as it may interfere with the healing of the skin edges. This is due to simple mechanical interposition of dry collagen and not due to any intrinsic interference with wound healing.

    • It has been reported with other collagen hemostatic agents, that by filling porosities of cancellous bone, they may significantly reduce the bond strength of methylmethacrylate adhesives. Avitene™ Ultrafoam™ sponge should not, therefore, be employed on bone surfaces to which prosthetic materials are to be attached with methylmethacrylate adhesives.


    Warnings

    • Avitene™ Ultrafoam™ sponge is inactivated by autoclaving.

    • Ethylene oxide reacts with bound hydrochloric acid to form ethylene chlorohydrin.

    • This device has been designed for single use only. Reuse, reprocessing, resterilization or repackaging may compromise the structural integrity and/or essential material and design characteristics that are critical to the overall performance of the device and may lead to device failure which may result in injury to the patient. Reuse, reprocessing, resterilization or repackaging may also create a risk of contamination of the device and/or cause patient infection or cross infection, including, but not limited to, the transmission of infectious diseases from one patient to another. Contamination of the device may lead to injury, illness or death of the patient or end user. Opened, unused product should be discarded.

    • As with any foreign substance, use of Avitene™ Ultrafoam™ sponge in contaminated wounds may enhance infection.

    • Avitene™ Ultrafoam™ sponge should not be used in instances of pumping arterial hemorrhage.

    • It should not be used where blood or other fluids have pooled, or in cases where the point of hemorrhage is submerged as it may mask an underlying source of bleeding, resulting in hematoma.

    • Avitene™ Ultrafoam™ sponge will not act as a tampon or plug in a bleeding site, nor will it close off an area of blood collecting behind a tampon.

    • Avitene™ Ultrafoam™ sponge is not intended to treat systemic coagulation disorders.

    • Not for injection, intraocular or intravascular use.


    Adverse Reactions

    • The most serious adverse reactions reported, which may be related to the use of other collagen products, are potentiation of infection including abscess formation, hematoma, wound dehiscence and mediastinitis.

    • Other reported adverse reactions possibly related are adhesion formation, allergic reaction, foreign body reaction and subgaleal seroma (report of a single case), and increased incidence of alveolalgia when used for packing of dental extraction sockets.

     

    true

    BD-52028 (08/22)

    true